Attached files

file filename
EX-10.12 - EX-10.12 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-10_12.htm
EX-32.1 - EX-32.1 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-32_1.htm
EX-31.2 - EX-31.2 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-31_2.htm
EX-31.1 - EX-31.1 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-31_1.htm
EX-23.1 - EX-23.1 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-23_1.htm
EX-21.1 - EX-21.1 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-21_1.htm
EX-10.13 - EX-10.13 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-10_13.htm
EX-10.11 - EX-10.11 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-10_11.htm
EX-10.10 - EX-10.10 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-10_10.htm
EX-3.1 - EX-3.1 - MADRIGAL PHARMACEUTICALS, INC.a2231593zex-3_1.htm
10-K - 10-K - MADRIGAL PHARMACEUTICALS, INC.a2231593z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

        We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-187242, No. 333-206135) and Form S-8 (No. 333-141903, No. 333-152824, No. 333-173862, No. 333-181117, No. 333-187243, No. 333-194477, No. 333-202680, No. 333-206128, No. 333-212615) of Madrigal Pharmaceuticals, Inc. of our report dated March 31, 2017 relating to the financial statements, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania
March 31, 2017




QuickLinks

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM